Literature DB >> 15263889

A statistical model for functional mapping of quantitative trait loci regulating drug response.

Y Gong1, Z Wang, T Liu, W Zhao, Y Zhu, J A Johnson, R Wu.   

Abstract

Differential drug response, that is, pharmacodynamics, is most often likely to be a complex trait, controlled by the combined influences of multiple genes and environmental influences. Genetic mapping has proven to be a powerful tool for detecting and identifying specific genes affecting complex traits, that is, quantitative trait loci (QTL), based on polymorphic markers. In this article, we present a novel statistical model for genetic mapping of QTL governing pharmacodynamic processes. In principle, this model is a combination of functional mapping proposed to map function-valued traits and linkage disequilibrium mapping designed to provide high-resolution mapping of QTL by making use of recombination events created at a historic time. We implement a closed-form solution for the Expectation-Maximization algorithm to estimate the population genetic parameters of QTL and the simplex algorithm to estimate the curve parameters describing the pharmacodynamic changes of different QTL genotypes in response to drug dose or concentrations. Extensive simulations are performed to investigate the statistical properties of our model. The implications of our model in pharmacogenetic and pharmacogenomic research are discussed.

Mesh:

Substances:

Year:  2004        PMID: 15263889     DOI: 10.1038/sj.tpj.6500262

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  2 in total

Review 1.  A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics.

Authors:  Rongling Wu; Chunfa Tong; Zhong Wang; David Mauger; Kelan Tantisira; Stanley J Szefler; Vernon M Chinchilli; Elliot Israel
Journal:  Drug Discov Today       Date:  2011-09-06       Impact factor: 7.851

2.  Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma.

Authors:  Y Wang; C Tong; Z Wang; Z Wang; D Mauger; K G Tantisira; E Israel; S J Szefler; V M Chinchilli; H A Boushey; S C Lazarus; R F Lemanske; R Wu
Journal:  Pharmacogenomics J       Date:  2015-01-20       Impact factor: 3.550

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.